newsfilter
← Latest News
GlobeNewswire·

KemPharm to Participate in Maxim's 2022 Virtual Growth Conference

CELEBRATION, Fla., March 24, 2022 (GLOBE NEWSWIRE) -- KemPharm, Inc. (NASDAQ:KMPH), a specialty pharmaceutical company focused on the discovery and development of proprietary prodrugs, today announced that Travis C. Mickle, Ph.D., President and CEO of